Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups

Medtech Talk
08/06/2017 18 min
Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups

Listen "Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups "

Descargar episodio

Episode Synopsis

Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups.

More episodes of the podcast Medtech Talk

From Boston Scientific to Entrepreneur: Chas McKhann’s Medtech Journey 26/08/2025
Innovating for Niche Populations with Eric Chehab and James Wall 29/07/2025
Episode: 197 - Fireside Chat: How Michael Mahoney Built a Culture of Disciplined Innovation at Boston Scientific 15/07/2025
Episode: 196 - Eric Wichems on Building a Company You Want to Work For 21/05/2025
Episode: 195 - John Woock on Crossing the Chasm from Clinical to Commercial 29/04/2025
Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation 27/03/2025
Episode:193 - Dr. Billy Cohn on Limitless Innovation and Finding Resources Everywhere 18/02/2025
Episode: 192 - Michael Jaff's Multi-Perspective Insights Into Healthcare 02/12/2024
Episode: 191 - Per Langoe on Bringing New Hope to Brain Cancer Patients 15/10/2024
Episode: 190 - The Evolution of Suki and Bringing Joy Back to Patient Care 17/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA